Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Synapse

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    December 2017
  1. FRANKLE WG, Robertson B, Maier G, Paris J, et al
    An Open-Label Positron Emission Tomography (PET) Study to Evaluate Serotonin Transporter Occupancy Following Escalating Dosing Regimens of (R)-(-)-O-desmethylvenlafaxine and Racemic O-Desmethylvenlafaxine.
    Synapse. 2017 Dec 7. doi: 10.1002/syn.22021.
    PubMed     Text format     Abstract available


    November 2017
  2. NAGANO-SAITO A, Lissemore JI, Gravel P, Leyton M, et al
    Posterior dopamine D2/3 receptors and brain network functional connectivity.
    Synapse. 2017;71.
    PubMed     Text format     Abstract available


    August 2017
  3. LAO PJ, Betthauser TJ, Tudorascu DL, Barnhart TE, et al
    [(18) F]Nifene test-retest reproducibility in first-in-human imaging of alpha4beta2* nicotinic acetylcholine receptors.
    Synapse. 2017;71.
    PubMed     Text format     Abstract available


    April 2017
  4. MISHINA M, Ishii K, Kimura Y, Suzuki M, et al
    Adenosine A1 receptors measured with 11 C-MPDX PET in early Parkinson's disease.
    Synapse. 2017 Apr 13. doi: 10.1002/syn.21979.
    PubMed     Text format     Abstract available


    February 2017
  5. FRANKLE WG, Narendran R, Wood AT, Suto F, et al
    Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [11 C]PBR28.
    Synapse. 2017 Feb 28. doi: 10.1002/syn.21970.
    PubMed     Text format     Abstract available


  6. LE FOLL B, Thiruchselvam T, Lu SX, Mohammed S, et al
    Investigating the effects of norepinephrine alpha1 receptor blockade on dopamine levels: A pilot PET study with [11 C]-(+)-PHNO in controls.
    Synapse. 2017 Feb 24. doi: 10.1002/syn.21968.
    PubMed     Text format     Abstract available


    November 2016
  7. MUKHERJEE J, Majji D, Kaur J, Constantinescu CC, et al
    PET Radiotracer Development for Imaging High-Affinity State of Dopamine D2 and D3 Receptors: Binding Studies of Fluorine-18 Labeled Aminotetralins in Rodents.
    Synapse. 2016 Nov 19. doi: 10.1002/syn.21950.
    PubMed     Text format     Abstract available


    April 2016
  8. MEJIAS M, Yu J, Mackey S, Dinelle K, et al
    Interpreting DTBZ binding data in rodent: Inherent variability and compensation.
    Synapse. 2016;70:147-52.
    PubMed     Text format     Abstract available


    March 2016
  9. ZHENG MQ, Lin SF, Holden D, Naganawa M, et al
    Comparative evaluation of two glycine transporter 1 radiotracers [11C]GSK931145 and [18F]MK-6577 in baboons.
    Synapse. 2016;70:112-20.
    PubMed     Text format     Abstract available


    February 2016
  10. TAKANO A, Stepanov V, Nakao R, Amini N, et al
    Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [ C]T-773 in nonhuman primates.
    Synapse. 2016 Feb 15. doi: 10.1002/syn.21896.
    PubMed     Text format     Abstract available


    January 2016
  11. PAN ML, Mukherjee MT, Patel HH, Patel B, et al
    Evaluation of [ C]TAZA for amyloid beta plaque imaging in post-mortem human alzheimer's disease brain region and whole body distribution in Rodent PET/CT.
    Synapse. 2016 Jan 25. doi: 10.1002/syn.21893.
    PubMed     Text format     Abstract available


  12. LEURQUIN-STERK G, Postnov A, de Laat B, Casteels C, et al
    Kinetic modelling and long-term test-retest reproducibility of the mGluR5 PET tracer F-FPEB in human brain.
    Synapse. 2016 Jan 21. doi: 10.1002/syn.21890.
    PubMed     Text format     Abstract available


    April 2015
  13. COSGROVE KP, Veldhuizen MG, Sandiego CM, Morris ED, et al
    Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
    Synapse. 2015;69:195-202.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: